FDA Panel: Argus II Artificial Retina’s Benefits Outweigh Risks
This article was originally published in The Gray Sheet
Executive Summary
Second Sight Medical Products gains FDA panel endorsement for humanitarian device exemption approval of Argus II, which would be the first artificial retina available to restore vision to the blind.